Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Core Insights - Autonomix Medical, Inc. is set to present at the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025, in New York, NY [1] - The company focuses on innovative technologies for diagnosing and treating diseases of the nervous system, with a first-in-class platform technology that includes a catheter-based microchip sensing array [4][5] - The initial application of this technology is aimed at treating pain associated with pancreatic cancer, a condition currently lacking reliable treatment options [5] Company Overview - Autonomix Medical, Inc. specializes in medical devices that aim to revolutionize the diagnosis and treatment of nervous system diseases [4] - The company's technology is designed to detect and differentiate neural signals with greater sensitivity than existing technologies, enabling transvascular diagnosis and treatment of peripheral nervous system diseases [4] - The investigational technology has not yet received marketing clearance in the United States [5] Conference Participation - Management will be available for in-person one-on-one meetings with qualified investors registered for the conference [2] - A video webcast of the presentation will be available on-demand starting September 8, 2025, at 7:00 AM ET, and will be archived for 90 days [3]